Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 15.7.2021Accord Healthcare S.L.U (ACC-ES)8432AMemantine Accord 20 mg filmom obalené tablety (tbl flm 56x20 mg (blis.PVC/PE/PVDC/Al))15.8.2021Z
 15.7.2021Accord Healthcare Polska Sp. z o.o. (AOK)8672BBupivakaín Accord 5 mg/ml injekčný roztok (sol inj 10x10 ml/50 mg (amp.skl.))16.7.2021Z
 15.7.2021Accord Healthcare Polska Sp. z o.o. (AOK)22763Donepezil Accord 10 mg filmom obalené tablety (tbl flm 98x10 mg (blis.PVC/Al))19.7.2021Z
 15.7.2021Accord Healthcare Polska Sp. z o.o. (AOK)22425Carboplatin Accord 10 mg/ml infúzny koncentrát (con inf 1x5 ml/50 mg (liek.skl.hnedá))19.7.2021Z
 15.7.2021Accord Healthcare S.L.U (ACC-ES)2233BAccofil 48 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke (sol ijf 5x0,5 ml (striek.inj.napl.skl.))16.7.2021R
 15.7.2021Accord Healthcare Polska Sp. z o.o. (AOK)2774ATopotecan Accord 1 mg/ml infúzny koncentrát (con inf 1x4 ml/4 mg (liek.inj.skl.jantárová))16.7.2021O
 15.7.2021Accord Healthcare Polska Sp. z o.o. (AOK)20076Epirubicin Accord 2 mg/ml (sol ijf 1x25 ml/50 mg (liek.inj.skl.s bielym/modrým viečkom))15.7.2021O
 15.7.2021B.Braun Melsungen AG (BME)26923Kaliumchlorid B. Braun 7,45 % (con inf 20x20 ml (amp.PE))15.7.2021R
 15.7.2021Zentiva, k.s. (ZNT-1)0570BOzzion 20 mg gastrorezistentné tablety (tbl ent 98x20 mg (blis.nylon/Al/PVC/Al))15.7.2021R
 14.7.2021XANTIS PHARMA LIMITED (XNT-1)89417Meloxikam Xantis 15 mg (tbl 20x15 mg (blis.OPA/Al/PVC/Al))20.7.2021R
 14.7.2021Dr. August Wolff GmbH & Co. KG Arzneimittel (DRG)92410Alpicort F 0,05 mg/ml + 2 mg/ml + 4 mg/ml dermálny roztok (sol der 1x100 ml (fľ.skl.))1.7.2021R
 13.7.2021Mundipharma Gesellschaft m.b.H. (MUP-A-2)22824Targin 20/10 mg tablety s predĺženým uvoľňovaním (tbl plg 60x20 mg/10 mg (blis.PVC/Al))14.7.2021R
 13.7.2021Mylan IRE Healthcare Limited (MYR)41327Gopten 4 mg (cps 56x4 mg (blis.PVC/PVDC/Al))19.7.2021R
 13.7.2021Mylan IRE Healthcare Limited (MYR)43229Gopten 2 mg (cps 98x2 mg (blis.PVC/PVDC/Al))20.7.2021O
 13.7.2021Mylan IRE Healthcare Limited (MYR)49450Gopten 0,5 mg (cps 20x0,5 mg (blis.PVC/PVDC/Al))20.7.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)